Cargando…
The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases
A better understanding of cytokine biology over the last two decades has allowed the successful development of cytokine inhibitors against tumour necrosis factor and interleukin (IL)-1 and IL-6. The introduction of these therapies should be considered a breakthrough in the management of several rheu...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714102/ https://www.ncbi.nlm.nih.gov/pubmed/19519923 http://dx.doi.org/10.1186/ar2680 |